PERSONALIZED MEDICINE In an Era of Health Care Reform
Venue: AAAS Headquarters
|Event Date/Time: Oct 26, 2009||End Date/Time: Oct 27, 2009|
The colloquium will address personalized medicine through a health care reform lens. Keynote speaker Francis Collins, NIH Director, will explain how his agency is addressing the scientific and policy challenges of personalized medicine, and a FDA official is invited to describe that agencyâ€™s role in personalized medicine. Other topics will include comparative effectiveness research; the use of health IT in research and clinical practice, as well as the ethical, legal, and policy implications of the transition to electronic health records; and the status of biomarker research, along with case studies illustrating the application of that research in targeting drug treatment, refining doses, and avoiding adverse events. At the colloquiumâ€™s conclusion, a panel will interact with the audience to discuss the difficult choices involved in clinical care in an era of personalized medicine from the perspective of a physician, a patient, an insurance official, and an attorney.
The colloquia series is free and open to the public, but registration is required.
WHAT: Colloquium II
In an Era of Health Care Reform
WHEN: October 26-27, 2009
WHERE: AAAS Headquarters
1200 New York Ave., NW
(12th and H Street entrance)
AAAS and FDLI would like to thank 3M, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb, Celera, Greenwall Foundation, Hoffmann-La Roche, and Johnson & Johnson for their support.